search
Back to results

OBDIPHY (OBesity DIgital-PHYsical Care Study) (OBDIPHY)

Primary Purpose

Pediatric Obesity, Obesity, Adolescent Obesity

Status
Recruiting
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Digital-physical care
Treatment as usual
Sponsored by
Göteborg University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pediatric Obesity

Eligibility Criteria

10 Years - 16 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • ISO-BMI 30 or above.

Exclusion Criteria:

  • Lack of Swedish skills
  • Patients potential for obesity surgery
  • Patient with obesity syndrome

Sites / Locations

  • Regionalt obesitascentrumRecruiting
  • Barnkliniken HallandRecruiting
  • Barnkliniken HallandRecruiting
  • Överviktenheten BarnRecruiting
  • Barnkliniken HallandRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Digital-physical care group

Treatment as usual.

Arm Description

Combination of digital and physical care.

Treatment as usual in accordance with national guidelines.

Outcomes

Primary Outcome Measures

Change from baseline in BMI standard deviation score at month 12.
The BMI standard-deviation score is a measure of the number of standard deviations from the population mean BMI (weight divided by height squared), matched for age and sex.

Secondary Outcome Measures

Change from baseline in BMI standard deviation score at month 6.
The BMI standard-deviation score is a measure of the number of standard deviations from the population mean BMI (weight divided by height squared), matched for age and sex.
Change from baseline in BMI standard deviation score at month 18.
The BMI standard-deviation score is a measure of the number of standard deviations from the population mean BMI (weight divided by height squared), matched for age and sex.
Change from baseline in weight at month 3.
Weight in kilogram measure in clinic at the hospital scales from TANITA or self monitored at home on a Beurer BF 850 scale.
Change from baseline in weight at month 6.
Weight in kilogram measure in clinic at the hospital scales from TANITA or self monitored at home on a Beurer BF 850 scale.
Change from baseline in weight at month 9.
Weight in kilogram measure in clinic at the hospital scales from TANITA or self monitored at home on a Beurer BF 850 scale.
Change from baseline in weight at month 12.
Weight in kilogram measure in clinic at the hospital scales from TANITA or self monitored at home on a Beurer BF 850 scale.
Change from baseline in weight at month 18.
Weight in kilogram measure in clinic at the hospital scales from TANITA or self monitored at home on a Beurer BF 850 scale.
Change from baseline in waist circumference at 6 and 12 month.
Waist circumference measure in cm with measuring tape.
Change from baseline in waist circumference at 6 month.
Waist circumference measure in cm with measuring tape.
Change from baseline in blood pressure at12 month.
Bloodpressure in mm Hg, measured in right arm while sitting down after 5 minits of rest. It will be measured three times and then the mean of the two last measure will be calculated and reported.
Change from baseline in fasting insulin at 12 month.
Fasting insulin from blood sample measured in mU/L. Analyzed according to standard routine.
Change from baseline in fasting glucose at 12 month.
Fasting glucose from blood sample measured in mmol/L. Analyzed according to standard routine.
Change from baseline in HbA1c at 12 month.
HbA1c from blood sample measured in mmol/L. Analyzed according to standard routine.
Change from baseline in lever enzymes, ASAT, at 12 month.
ASAT from blood sample measured in µkat/L. Analyzed according to standard routine.
Change from baseline in lever enzymes, ALAT, at 12 month.
ALAT from blood sample measured in µkat/L. Analyzed according to standard routine.
Change from baseline in triglyceride at 12 month.
Triglyceride from blood sample measured in mmol/L. Analyzed according to standard routine.
Change from baseline in cholesterol at 12 month.
Cholesterol from blood sample measured in mmol/L. Analyzed according to standard routine.
Change from baseline in blood lipid, LDL, at 12 month.
LDL from blood sample measured in mmol/L. Analyzed according to standard routine.
Change from baseline in blood lipid, HDL, at 12 month.
HDL from blood sample measured in mmol/L. Analyzed according to standard routine.
Change from baseline in food intake according to Riksmaten Flex and 24-hour recalls in 12 month.
RiksmatenFlex and 24-hour recalls is a validated survey about food habits combined with three 24-hour interviews, where food intake the last 24 h are reported.
Change from baseline in amount of steps per day according to activity watch at week 52.
Amount of daily steps will be self-monitored with a sportsbuddy veryfit activity watch and then selfreported in to the study app. The mean of one weeks step will be colected at week 1, 26 and 52.
Change from baseline in amount of steps per day according to activity watch at week 26.
Amount of daily steps will be self-monitored with a sportsbuddy veryfit activity watch and then selfreported in to the study app. The mean of one weeks step will be collected at week 1, 26 and 52.
Change from baseline in health-related quality of life according to PEDS-QL at 12 month
PEDS-QL is a valid questionaire for evaluating health-related quality of life used by the Swedish childhood obesity treatment register (BORIS). The child will answer if they never, almost never, sometimes, often or always has experience diffrent issues conserning their health.
Change from baseline in daily well-being on a 10 point VAS-scale at week 26.
Daily self reported well-being via a VAS-scale from 1-10 (1=worst feeling, 10=best feeling). The mean of one week reported data will be collected at week 1, 26 and 52.
Change from baseline in daily well-being on a 10 point VAS-scale at week 52.
Daily self reported well-being via a VAS-scale from 1-10 (1=worst feeling, 10=best feeling). The mean of one week reported data will be collected at week 1, 26 and 52.
Thoughts on implementation from caregivers after a 12-month digital-physical care.
Survey about caregivers experience through implementation of digital care. Few easy questions about positive and negative aspects.
Thoughts on implementation from patients after a 12-month digital-physical care.
Survey about patient experience through implementation of digital care. Few easy questions about positive and negative aspects and how they used the app.
Semi-structured interviews for a deeper insight in the qualitative aspects concerning digital care.
Semi-structured interviews with 15-20 of the patient families inte the intervention group. The interview will proceed from open answer questions with the possibility to expand answers.

Full Information

First Posted
December 7, 2021
Last Updated
June 12, 2023
Sponsor
Göteborg University
Collaborators
Region Skane, Vastra Gotaland Region, Karolinska Institutet
search

1. Study Identification

Unique Protocol Identification Number
NCT05247918
Brief Title
OBDIPHY (OBesity DIgital-PHYsical Care Study)
Acronym
OBDIPHY
Official Title
OBDIPHY (OBesity DIgital-PHYsical Care Study) - Effects of Digi-physical Care for Families
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 9, 2022 (Actual)
Primary Completion Date
May 30, 2023 (Actual)
Study Completion Date
December 31, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Göteborg University
Collaborators
Region Skane, Vastra Gotaland Region, Karolinska Institutet

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This is a prospective randomized controlled multicentre non-inferiority trial. The aim of this study to evaluate digi-physical care compared to regular physical/in person care and investigate if digi-physical care can be an equal or even better treatment alternative among families with children or adolescents living with obesity in Sweden. The study participants will either get treatment as usual or treatment as usual combined with digi-physical solution. The digi-physical solution includes thar half of the session is digital and they get an app where they can self-monitoring health data, have an overview over they treatment plan and easy communicate with theirs caregivers.
Detailed Description
This study is multi centre in three different county council in southwest of Sweden which include children and adolescents in the age of 10-16 year. The study participants will either get treatment as usual, which includes four in person session with healthcare professionals as doctor, nurse or dietitian (the control group) or treatment as usual combined with digi-physical solution (intervention group). The intervention group will beyond treatment as usual get a digital communication platform (including an app) where the patient has a good overview of their treatment plan, can report self-monitored health data as daily steps and weight once a week and monitor the daily work with their selected health goal. Everything in the app is individually tailored together with the patient. The patient with digi-physical care will also have assess to a chat for communication with their caregivers. The app has a high degree of authentication and classified as a journal system. Half of yearly treatment as usual sessions will be digital for the intervention group. The digi-physical method of treatment is developed and based on the desire from the patient association HOBS (hälsa oberoende av storlek). In parts of Sweden people have long distance to the clinic which makes it difficult to be present at the treatment in-clinic sessions and the families loses many hours away from school and work. The null hypothesis is that digi-physical care will have a positive effect on BMI SDS, however inferior to treatment as usual. In addition to evaluate that this new treatment alternative is safe will also ISO-BMI, weight development and metabolic risk factors be evaluated. The study does not include any extra blood samples or visits to the clinic thus everything is collected according to regular care programs. To evaluate the food intake and possible changes there will be three 24-h recalls, combined with riksmaten flex, performed. There will also be questions about their physical activity and a survey (PEDS-QL) for mental health. For a few volunteered patient families, approximate 15-20, will participate in semi-structured deep interviews.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pediatric Obesity, Obesity, Adolescent Obesity, Lifestyle Risk Reduction, Metabolic Syndrome, Weight Loss

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Multicenter prospective randomized controlled trial.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
112 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Digital-physical care group
Arm Type
Experimental
Arm Description
Combination of digital and physical care.
Arm Title
Treatment as usual.
Arm Type
Active Comparator
Arm Description
Treatment as usual in accordance with national guidelines.
Intervention Type
Behavioral
Intervention Name(s)
Digital-physical care
Intervention Description
Patients will get access to a digital communication platform. Two in person session and two digital contacts per year with possibility to chat with caregivers in between.
Intervention Type
Behavioral
Intervention Name(s)
Treatment as usual
Intervention Description
Four in person session at the center in a year.
Primary Outcome Measure Information:
Title
Change from baseline in BMI standard deviation score at month 12.
Description
The BMI standard-deviation score is a measure of the number of standard deviations from the population mean BMI (weight divided by height squared), matched for age and sex.
Time Frame
Baseline and month 12.
Secondary Outcome Measure Information:
Title
Change from baseline in BMI standard deviation score at month 6.
Description
The BMI standard-deviation score is a measure of the number of standard deviations from the population mean BMI (weight divided by height squared), matched for age and sex.
Time Frame
Baseline and month 6.
Title
Change from baseline in BMI standard deviation score at month 18.
Description
The BMI standard-deviation score is a measure of the number of standard deviations from the population mean BMI (weight divided by height squared), matched for age and sex.
Time Frame
Baseline and month 18
Title
Change from baseline in weight at month 3.
Description
Weight in kilogram measure in clinic at the hospital scales from TANITA or self monitored at home on a Beurer BF 850 scale.
Time Frame
Baseline and month 3.
Title
Change from baseline in weight at month 6.
Description
Weight in kilogram measure in clinic at the hospital scales from TANITA or self monitored at home on a Beurer BF 850 scale.
Time Frame
Baseline and month 6.
Title
Change from baseline in weight at month 9.
Description
Weight in kilogram measure in clinic at the hospital scales from TANITA or self monitored at home on a Beurer BF 850 scale.
Time Frame
Baseline and month 9..
Title
Change from baseline in weight at month 12.
Description
Weight in kilogram measure in clinic at the hospital scales from TANITA or self monitored at home on a Beurer BF 850 scale.
Time Frame
Baseline and month 12.
Title
Change from baseline in weight at month 18.
Description
Weight in kilogram measure in clinic at the hospital scales from TANITA or self monitored at home on a Beurer BF 850 scale.
Time Frame
Baseline and month 18.
Title
Change from baseline in waist circumference at 6 and 12 month.
Description
Waist circumference measure in cm with measuring tape.
Time Frame
Baseline and month 6 and 12.
Title
Change from baseline in waist circumference at 6 month.
Description
Waist circumference measure in cm with measuring tape.
Time Frame
Baseline and month 6.
Title
Change from baseline in blood pressure at12 month.
Description
Bloodpressure in mm Hg, measured in right arm while sitting down after 5 minits of rest. It will be measured three times and then the mean of the two last measure will be calculated and reported.
Time Frame
Baseline and month 12.
Title
Change from baseline in fasting insulin at 12 month.
Description
Fasting insulin from blood sample measured in mU/L. Analyzed according to standard routine.
Time Frame
Baseline and month 12.
Title
Change from baseline in fasting glucose at 12 month.
Description
Fasting glucose from blood sample measured in mmol/L. Analyzed according to standard routine.
Time Frame
Baseline and month 12.
Title
Change from baseline in HbA1c at 12 month.
Description
HbA1c from blood sample measured in mmol/L. Analyzed according to standard routine.
Time Frame
Baseline and month 12.
Title
Change from baseline in lever enzymes, ASAT, at 12 month.
Description
ASAT from blood sample measured in µkat/L. Analyzed according to standard routine.
Time Frame
Baseline and month 12.
Title
Change from baseline in lever enzymes, ALAT, at 12 month.
Description
ALAT from blood sample measured in µkat/L. Analyzed according to standard routine.
Time Frame
Baseline and month 12.
Title
Change from baseline in triglyceride at 12 month.
Description
Triglyceride from blood sample measured in mmol/L. Analyzed according to standard routine.
Time Frame
Baseline and month 12.
Title
Change from baseline in cholesterol at 12 month.
Description
Cholesterol from blood sample measured in mmol/L. Analyzed according to standard routine.
Time Frame
Baseline and month 12.
Title
Change from baseline in blood lipid, LDL, at 12 month.
Description
LDL from blood sample measured in mmol/L. Analyzed according to standard routine.
Time Frame
Baseline and month 12.
Title
Change from baseline in blood lipid, HDL, at 12 month.
Description
HDL from blood sample measured in mmol/L. Analyzed according to standard routine.
Time Frame
Baseline and month 12.
Title
Change from baseline in food intake according to Riksmaten Flex and 24-hour recalls in 12 month.
Description
RiksmatenFlex and 24-hour recalls is a validated survey about food habits combined with three 24-hour interviews, where food intake the last 24 h are reported.
Time Frame
Baseline and month 12.
Title
Change from baseline in amount of steps per day according to activity watch at week 52.
Description
Amount of daily steps will be self-monitored with a sportsbuddy veryfit activity watch and then selfreported in to the study app. The mean of one weeks step will be colected at week 1, 26 and 52.
Time Frame
Baseline (week 1) and 52.
Title
Change from baseline in amount of steps per day according to activity watch at week 26.
Description
Amount of daily steps will be self-monitored with a sportsbuddy veryfit activity watch and then selfreported in to the study app. The mean of one weeks step will be collected at week 1, 26 and 52.
Time Frame
Baseline (week 1) and week 26.
Title
Change from baseline in health-related quality of life according to PEDS-QL at 12 month
Description
PEDS-QL is a valid questionaire for evaluating health-related quality of life used by the Swedish childhood obesity treatment register (BORIS). The child will answer if they never, almost never, sometimes, often or always has experience diffrent issues conserning their health.
Time Frame
Baseline and month 12.
Title
Change from baseline in daily well-being on a 10 point VAS-scale at week 26.
Description
Daily self reported well-being via a VAS-scale from 1-10 (1=worst feeling, 10=best feeling). The mean of one week reported data will be collected at week 1, 26 and 52.
Time Frame
Baseline (week 1), and week 26.
Title
Change from baseline in daily well-being on a 10 point VAS-scale at week 52.
Description
Daily self reported well-being via a VAS-scale from 1-10 (1=worst feeling, 10=best feeling). The mean of one week reported data will be collected at week 1, 26 and 52.
Time Frame
Baseline (week 1) and 52.
Title
Thoughts on implementation from caregivers after a 12-month digital-physical care.
Description
Survey about caregivers experience through implementation of digital care. Few easy questions about positive and negative aspects.
Time Frame
At month 12
Title
Thoughts on implementation from patients after a 12-month digital-physical care.
Description
Survey about patient experience through implementation of digital care. Few easy questions about positive and negative aspects and how they used the app.
Time Frame
At month 12
Title
Semi-structured interviews for a deeper insight in the qualitative aspects concerning digital care.
Description
Semi-structured interviews with 15-20 of the patient families inte the intervention group. The interview will proceed from open answer questions with the possibility to expand answers.
Time Frame
At month 12.
Other Pre-specified Outcome Measures:
Title
Report digital selfmonitored health data.
Description
Evaluate the precentage of typ 2 diabetes patientens that reported self-monitored health data by the digital communication platform.
Time Frame
At 3 month.

10. Eligibility

Sex
All
Gender Based
Yes
Minimum Age & Unit of Time
10 Years
Maximum Age & Unit of Time
16 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: ISO-BMI 30 or above. Exclusion Criteria: Lack of Swedish skills Patients potential for obesity surgery Patient with obesity syndrome
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lovisa Sjögren
Phone
+46707144749
Email
lovisa.sjogren@regionhalland.se
First Name & Middle Initial & Last Name or Official Title & Degree
Terese Torstensson
Email
terese.torstensson@regionhalland.se
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Josefin Roswall
Organizational Affiliation
Region Halland
Official's Role
Study Chair
Facility Information:
Facility Name
Regionalt obesitascentrum
City
Göteborg
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lovisa Sjögren, MD
Email
lovisa.sjogren@regionhalland.se
Facility Name
Barnkliniken Halland
City
Halmstad
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lovisa Sjögren
Email
lovisa.sjogren@regionhalland.se
Facility Name
Barnkliniken Halland
City
Kungsbacka
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lovisa Sjögren
Email
lovisa.sjogren@regionhalland.se
Facility Name
Överviktenheten Barn
City
Malmö
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lovisa Sjögren
Phone
+46707144749
Email
lovisa.sjogren@regionhalland.se
Facility Name
Barnkliniken Halland
City
Varberg
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lovisa Sjögren
Email
lovisa.sjogren@regionhalland.se

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

OBDIPHY (OBesity DIgital-PHYsical Care Study)

We'll reach out to this number within 24 hrs